Filtros de búsqueda

Lista de obras de Robert Flisiak

A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.

artículo científico publicado en 2016

A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.

artículo científico publicado en 2016

A pill for HCV - myth or foreseeable future?

artículo científico publicado en 2013

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

artículo científico publicado en 2014

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

artículo científico publicado en 2011

Acute hepatitis E complicated by acute pancreatitis: a case report and literature review.

artículo científico publicado en 2005

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

artículo científico publicado en 2016

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

artículo científico publicado en 2010

Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis C.

artículo científico publicado en 2008

Albinterferon-alfa 2b: a new treatment option for hepatitis C ⬇️

artículo científico publicado el 1 de octubre de 2010

Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

artículo científico publicado en 2015

Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial.

artículo científico publicado en 2014

Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.

artículo científico publicado en 2015

Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020

artículo científico publicado en 2020

Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations

artículo científico publicado en 2010

Assessment of serum IGF-1 and adipokines related to metabolic dysfunction in HIV-infected adults.

artículo científico publicado en 2013

Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C

scientific article published on 16 November 2009

Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions

scientific article published on 01 August 2002

Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history

scientific article published on 23 March 2019

Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial

artículo científico publicado en 2016

Chance of hepatic fibrosis treatment in chronic hepatitis C

artículo científico publicado en 2004

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

artículo científico publicado en 2020

Changes in serological biomarkers of liver function and connective tissue turnover in chronic hepatitis B during lamivudine therapy

artículo científico publicado en 2005

Changing HCV genotypes distribution in Poland--relation to source and time of infection.

artículo científico publicado en 2008

Chronic HBV infection in patients with lymphoproliferative syndromes

artículo científico publicado en 2012

Chronic Viral Hepatitis and Metabolic Syndrome/Cardiovascular Risk

article published in 2018

Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients

artículo científico publicado en 2019

Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis

scientific article published on 01 June 2000

Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment

artículo científico publicado en 2008

Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy

artículo científico publicado en 2020

Clinical course of Lyme borreliosis with respect to the initial disease manifestation in Białowieza residents

artículo científico publicado en 2004

Clinical importance and diagnostic methods of minimal hepatic encephalopathy

artículo científico publicado en 2016

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.

artículo científico publicado en 2015

Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

artículo científico publicado en 2019

Computed tomography changes in lungs of COVID-19 patients

scientific article published on 18 May 2020

Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study

artículo científico publicado en 2020

Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

article

Correction: Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV-infected patients

artículo científico publicado en 2018

Cost-effectiveness of truncated therapy for hepatitis C based on rapid virologic response

artículo científico publicado en 2012

Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis

artículo científico

Cyclophilin inhibitors in hepatitis C viral infection

artículo científico publicado en 2007

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1

artículo científico publicado en 2016

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin

artículo científico publicado en 2013

Delayed HIV disease diagnosis, despite multiple hospitalizations--case report

artículo científico publicado en 2014

Delayed diagnosis of human immunodeficiency virus infection in a patient with non-specific neurological symptoms and pancytopenia: a case report

artículo científico publicado en 2014

Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases

artículo científico publicado en 2008

Distribution of HBV genotypes in Poland

artículo científico publicado en 2015

Distribution of HCV genotypes in Poland

artículo científico publicado en 2013

Drug rash with eosinophilia and systemic symptoms after ibuprofen intake.

artículo científico publicado en 2007

Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience study

artículo científico publicado en 2018

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

artículo científico publicado en 2010

Effect of COVID-19 on Anti-S Antibody Response in Healthcare Workers Six Months Post-Vaccination

artículo científico publicado en 2021

Effect of Peginterferon or Ribavirin Dosing on Efficacy of Therapy With Telaprevir in Treatment-Experienced Patients With Chronic Hepatitis C and Advanced Liver Fibrosis: A Multicenter Cohort Study.

artículo científico publicado en 2015

Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study

artículo científico publicado en 2019

Effect of exposure to tick-bites on the course of lyme borreliosis in Bialowieza residents

artículo científico publicado en 2002

Effect of hepatitis B virus (HBV) infection on the course of pregnancy and newborns' health status

artículo científico publicado en 2015

Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B

artículo científico publicado en 2004

Effect of misoprostol on serum beta2-microglobulin in the course of viral hepatitis B

artículo científico publicado en 1999

Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.

artículo científico publicado en 2005

Effect of ulcerative colitis activity on plasma concentration of transforming growth factor beta1

artículo científico publicado en 2001

Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa

artículo científico publicado en 2003

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

artículo científico publicado en 2021

Effectiveness and safety of ledipasvir/sofosbuvir±ribavirin in the treatment of HCV infection: The real-world HARVEST study.

artículo científico publicado en 2017

Effects of ethanol on prostanoid production by liver fat-storing cells

scientific article published on 01 July 1993

Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration

artículo científico publicado en 1999

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study.

artículo científico publicado en 2018

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.

artículo científico

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection

scientific article published on 10 December 2019

Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas

artículo científico publicado el 1 de enero de 2010

Efficacy of HCV treatment in Poland at the turn of the interferon era - the EpiTer study

artículo científico publicado en 2016

Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection

artículo científico publicado en 2014

Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

artículo científico publicado en 2005

Emerging treatments for hepatitis C.

artículo científico

Epidemiological and clinical characteristics of genotype 4 HCV infection in the north-east Poland

artículo científico publicado en 2009

Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.

artículo científico publicado en 2005

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland ⬇️

artículo científico publicado el 1 de marzo de 2011

Epidemiology of intra-marital infections with hepatitis B virus (HBV) among the patients hospitalized in the infectious disease clinics in the Białystok region 1988-1990

artículo científico publicado el 1 de enero de 1991

Epidemiology, diagnosis, and prevention of tick-borne encephalitis in Poland and selected european countries – a position statement of the polish group of experts

artículo científico publicado en 2021

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.

artículo científico publicado en 2015

Evaluation of alpha-glutathione-S-transferase as a biomarker of lamivudine therapy for chronic hepatitis B

scientific article published on 01 October 2006

Exacerbation of chronic hepatitis B during chemotherapy due to testicular seminoma

artículo científico publicado en 2012

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

artículo científico publicado en 2017

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

artículo científico publicado en 2021

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

scientific article published on 10 April 2020

Forecasting the disease burden of chronic hepatitis C virus in Poland

artículo científico publicado en 2015

Galectin-3 Concentration in Liver Diseases

artículo científico publicado en 2015

Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study

scientific article published in 2019

Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

artículo científico publicado en 2018

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

artículo científico publicado en 2018

Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoir

artículo científico publicado en 2015

HBV infection and pregnancy

artículo científico publicado el 1 de enero de 2010

HBV mutations and their clinical significance.

artículo científico publicado en 2012

HBV mutations associated with lamivudine therapy

artículo científico publicado en 2013

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

artículo científico publicado en 2022

HCV entry as a new therapeutic target in chronic hepatitis C

artículo científico publicado en 2009

Helicobacter pylori infection among patients with liver cirrhosis

artículo científico

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

scientific article published on 22 August 2018

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

artículo científico publicado en 2010

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection

artículo científico publicado en 2012

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

artículo científico publicado en 2022

Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals

scientific article published on 06 September 2019

Hepatitis C: efficacy and safety in real life.

artículo científico publicado en 2017

High concentration of antimitochondrial antibodies predicts progressive primary biliary cirrhosis

artículo científico publicado en 2005

High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.

artículo científico publicado en 2008

High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance

artículo científico publicado en 2014

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases

artículo científico publicado en 2017

Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

artículo científico publicado en 2015

How close are we to hepatitis C virus elimination in Central Europe?

artículo científico publicado en 2020

Hyaluronic acid concentration in liver diseases.

artículo científico publicado en 2015

Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection

artículo científico publicado en 2015

Impact of rs12979860 polymorphism on liver morphology in chronic HCV infection

scientific article published on 30 April 2015

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

artículo científico publicado en 2017

Incidence of tuberculosis and mycobacteriosis among HIV-infected patients--clinical and epidemiological analysis of patients from north-eastern Poland

artículo científico publicado en 2013

Increased plasma transforming growth factor-beta1 is associated with disease progression in HIV-1-infected patients.

artículo científico publicado en 2004

Influence of HCV and HIV on development of cryoglobulinemia

artículo científico publicado en 2015

Investigational drugs for hepatitis C.

artículo científico publicado en 2010

Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?

artículo científico publicado en 2018

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all HCV infected patients in the real-world experience?

artículo científico publicado en 2020

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

artículo científico publicado en 2014

Knowledge is coming so fast that a meta-analysis of COVID-19 treatment is always too late

artículo científico publicado en 2020

Known and probable risk factors for hepatitis C infection: a case series in north-eastern Poland

artículo científico publicado en 2006

Laboratory evidence for hypercoagulability in cirrhotic patients with history of variceal bleeding

artículo científico publicado en 2019

Liver damage in the course of Langerhans cells histiocytosis--case report

artículo científico publicado el 1 de febrero de 2012

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

artículo científico publicado en 2015

Long-term effects of HBV treatment Peg-IFN alfa-2a alone or combined with lamivudine

artículo científico publicado en 2007

Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders

artículo científico publicado en 2012

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

artículo científico publicado en 2020

Lyme borreliosis

artículo científico publicado en 2012

Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020

scientific article published on 29 October 2020

Management of hepatitis B and hepatitis C coinfection: an expert review

artículo científico publicado en 2020

Meeting of Initiative Group for Central European Hepatologic Collaboration (CEHC): Warsaw, 19-21 November 2015

artículo científico publicado en 2016

Metabolic abnormalities and cardiovascular risk in HIV-infected cohort of patients treated with protease inhibitors

artículo científico publicado en 2015

Metabolic syndrome and hepatitis C infection – brothers in arms ⬇️

artículo científico publicado el 19 de junio de 2013

Metabolic syndrome in HIV infected adults in Poland.

artículo científico publicado en 2018

Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.

artículo científico publicado en 2007

Morphological studies of the effects of protein-free diet and branched-chain amino acids (aminosteril-hepa (Frasenius)) on experimental thioacetamide-induced liver damage

artículo científico publicado en 1990

New therapeutic options for HCV in Central Europe

artículo científico publicado en 2016

Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C

artículo científico publicado en 2017

Occurrence and clinical characteristics of hepatocellular carcinoma in the north-eastern Poland

artículo científico publicado en 2017

Occurrence of autoantibodies in patients with alcoholic liver disease

artículo científico publicado el 1 de septiembre de 2012

Ombitasvir and paritaprevir boosted with ritonavir and combined with dasabuvir for chronic hepatitis C.

artículo científico publicado en 2017

Ombitasvir/paritaprevir/ritonavir plus dasabuvir combination in the treatment of chronic HCV infection.

artículo científico publicado en 2016

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study

artículo científico publicado en 2013

One year follow-up of patients treated with misoprostol in acute phase of viral hepatitis B.

artículo científico publicado en 2000

Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients

scientific article published on 08 July 2019

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection

artículo científico publicado en 2022

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2005

Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b.

artículo científico publicado en 2016

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis

artículo científico publicado en 2007

Perspectives of hepatitis C virus (HCV) elimination in Poland

artículo científico publicado en 2019

Plasma iPGE2 and i6-keto PGF1 alpha in the course of liver cirrhosis

artículo científico publicado en 1997

Plasma interleukin-18 is associated with viral load and disease progression in HIV-1-infected patients

scientific article published on 01 November 2004

Plasma interleukin-18 reflects severity of ulcerative colitis.

artículo científico publicado en 2005

Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.

artículo científico publicado en 2003

Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis

artículo científico publicado en 2002

Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B

artículo científico publicado en 2005

Plasma transforming growth factor β1as a biomarker of psoriasis activity and treatment efficacy ⬇️

artículo científico publicado el 1 de septiembre de 2003

Plasma transforming growth factor-beta(1) in acute viral hepatitis.

artículo científico publicado en 2005

Polish Group of Experts of HBV--collective to vaccinations: vaccinations against hepatitis A and B

artículo científico publicado el 1 de enero de 2012

Polish multicenter study on safety and efficacy of adefovir dipivoxil in the treatment of lamivudine resistant chronic hepatitis B in adults (HEP 2008)

artículo científico publicado el 1 de enero de 2011

Predictive factors of virological response in chronically HCV infected

artículo científico publicado el 1 de septiembre de 2012

Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe

artículo científico publicado en 2010

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.

artículo científico publicado en 2016

Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland

artículo científico publicado en 2015

Prevalence and risk factors of HCV infection in Poland

artículo científico publicado en 2011

Prevalence of HCV genotypes in Poland - the EpiTer study

artículo científico publicado en 2016

Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function

artículo científico publicado en 2009

Prevalence of syphilis among patients living with HIV treated in Bialystok HIV/AIDS Center

artículo científico publicado en 2017

Prevalence, clinical and therapeutical implications of active CMV infection in patients with chronic hepatitis C

artículo científico publicado en 2009

Prophylaxis of hepatitis B virus (HBV) infection reactivation - recommendations of the Working Group for prevention of HBV reactivation

artículo científico publicado en 2019

Quantitative measurement of HCV core antigen for management of interferon-free therapy in HCV infected patients

artículo científico publicado en 2017

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

artículo científico publicado en 2015

Randomized trial of albinterferon alfa‐2b every 4 weeks for chronic hepatitis C virus genotype 2/3 ⬇️

artículo científico publicado el 21 de marzo de 2012

Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial

artículo científico publicado en 2011

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy

artículo científico publicado en 2019

Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study

artículo científico publicado en 2017

Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study.

artículo científico publicado en 2016

Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A meta-analysis

artículo científico publicado en 2017

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.

artículo científico publicado en 2019

Real-world experience with ombitasvir/paritaprevir boosted with ritonavir and possibly combined with dasabuvir and ribavirin in HCV infection

artículo científico publicado en 2016

Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational

scientific article published on 05 March 2019

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)

Recommendations for the treatment of hepatitis B in 2017

artículo científico publicado en 2017

Recommendations for the treatment of hepatitis C Polish group of HCV Experts--2015

artículo científico publicado en 2015

Recommendations for the treatment of hepatitis C in 2017

artículo científico publicado en 2017

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts - 2016

artículo científico publicado en 2016

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts - 2015

scientific article published on 16 November 2015

Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists

artículo científico publicado en 2020

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020

artículo científico publicado en 2020

Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy

artículo científico publicado en 2022

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

artículo científico publicado en 2020

Respiratory functional impairment in patients with liver cirrhosis

artículo científico publicado el 1 de noviembre de 2011

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

artículo científico publicado en 2017

Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe

artículo científico publicado en 2017

Role of cannabinoids in chronic liver diseases

artículo científico publicado en 2008

SNP RS12979860 related spontaneous clearance of hepatitis c virus infection in HCV/HIV-1 coinfected patients.

artículo científico publicado en 2013

Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials

artículo científico publicado en 2019

Searching for the optimal population for hepatitis C virus screening in Poland

artículo científico publicado en 2020

Selected Noninvasive Markers in Diagnosing Liver Diseases

artículo científico publicado en 2015

Selected indices of immunoreactivity dependent on HBV infection in patients with alcoholic liver cirrhosis

artículo científico publicado el 1 de abril de 1991

Serum Concentrations of Th17-Associated Interleukins and Autoimmune Phenomena are Associated with the Degree of Liver Damage in Alcoholic Liver Disease

artículo científico publicado en 2017

Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease

artículo científico publicado en 2017

Serum HCV core antigen concentration in HCV monoinfection and HCV/HIV coinfection

artículo científico publicado en 2013

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

artículo científico publicado en 2013

Serum level of interleukin-6 (IL-6) and N-terminal propeptide of procollagen type I (PINP) in patients with liver diseases

artículo científico publicado en 2017

Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis

artículo científico publicado en 2008

Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection.

artículo científico publicado en 2014

Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland

artículo científico publicado en 2022

Signal transduction pathways in liver and the influence of hepatitis C virus infection on their activities

artículo científico publicado en 2009

Significance of mutations in the region coding for NS3/4 protease in patients infected with HCV genotype 1b

scientific article published on 01 November 2018

Sofosbuvir and ribavirin in HCV genotypes 2 and 3.

artículo científico publicado en 2014

Specific ssDNA concentration in liver tissue as an index of apoptosis in hepatitis C virus-infected patients.

artículo científico publicado en 2005

Specifically targeted antiviral therapy for hepatitis C virus

artículo científico publicado en 2007

Standards of hepatitis C treatment. Recommendations of Polish Group of Experts--2014

artículo científico publicado en 2014

Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.

artículo científico publicado en 2015

Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.

artículo científico publicado en 2010

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection ⬇️

artículo científico publicado el 23 de junio de 2011

Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

artículo científico publicado en 2019

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).

artículo científico publicado en 2014

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

artículo científico publicado en 2008

The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation

artículo científico publicado en 2021

The concentration of total sialic acid in chronic hepatitis B and C

artículo científico publicado en 2018

The cyclophilin inhibitor Debio 025 combined with PEG IFNalpha2a significantly reduces viral load in treatment-naïve hepatitis C patients.

artículo científico publicado en 2009

The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.

artículo científico publicado en 2008

The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins

artículo científico publicado en 2014

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases

The importance of sCD40 and sCD40L concentration in patients with chronic HCV infection and HIV co-infection

artículo científico publicado en 2014

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease

article

The justification for the early introduction of antiretroviral therapy in patients living with HIV.

artículo científico publicado en 2014

The occurrence of HCV genotypes and single polynucleotide polymorphisms of rs12979860 among HCV infected patients in northeastern Poland

artículo científico publicado en 2012

The occurrence of autoantibodies in patients with chronic HCV infection, including patients dialyzed and after kidney transplantation

artículo científico publicado en 2016

The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.

artículo científico publicado en 2015

The transferrin isoforms in chronic hepatitis.

artículo científico publicado en 2017

Therapeutic recommendations for 2013: antiviral treatment for chronic hepatitis B.

artículo científico publicado en 2013

Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection

artículo científico publicado en 2010

Therapeutic vaccination in chronic hepatitis B: chance or utopia?

artículo científico publicado en 2003

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

artículo científico publicado en 2010

Thyroid dysfunction in antiviral therapy of chronic hepatitis C

artículo científico publicado el 1 de julio de 2010

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

artículo científico publicado en 2021

Tocilizumab for patients with severe COVID-19: a retrospective, multi-centre study

artículo científico publicado en 2020

Total and free serum sialic acid concentration in liver diseases

artículo científico publicado en 2014

Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients.

artículo científico publicado en 2005

Transforming growth factor-beta1 as a surrogate marker of hepatic dysfunction in chronic liver diseases

scientific article published on 01 November 2000

Treatment of HCV infection in Poland at the beginning of the interferon-free era - the EpiTer-2 study

artículo científico publicado en 2018

Treatment of chronic hepatitis C in a patient with Fanconi anaemia.

artículo científico publicado en 2011

Treatment recommendations of chronic hepatitis B. Did the world escape us?

artículo científico publicado en 2008

Update on alisporivir in treatment of viral hepatitis C.

artículo científico publicado en 2012

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

artículo científico publicado en 2011

[Activity of the caspase-3 in the culture of peripheral blood mononuclear cells stimulated with Borrelia burgdorferi antigens]

artículo científico publicado en 2008

[Analysis of prognostic factors in patients with autoimmune hepatitis]

artículo científico publicado en 2006

[Cytokeratin 18 as an indicator of the activity of liver disease]

artículo científico publicado en 2011

[Influence of cryoglobulinaemia on renal function in patients with chronic HCV infection].

artículo científico publicado en 2009

[Polish Experts Group on HBV. Therapeutic recommendations on 2008 year (antiretroviral treatment of chronic hepatitis B)]

artículo científico publicado en 2008

[Prevalence of antibodies against hepatitis E virus among students from India living in Bialystok, Poland]

scientific article published on 01 January 2008

[Respiratory functional impairment in patients with liver cirrhosis]

artículo científico publicado en 2010

[Standards of hepatitis C treatment. Recommendations of Polish Group of Experts]

artículo científico publicado en 2012

siRNA drug development against hepatitis B virus infection

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda